Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews


Omniome developer of an innovative new DNA sequencing platform, today announced it has raised an additional $60 million with the completion of its Series B financing.  The funding round was led by Decheng Capital and Hillhouse Capital Group, joined by Lam Research Capital and Nan Fung Life Sciences as well as current investors ARCH Venture Partners, Domain Associates, Biomatics Capital Partners and Altitude Life Science Ventures.

Read more ...
OncoCyte, a developer of novel, non-invasive liquid biopsy diagnostic tests for the early detection of cancer, announced that it has entered into definitive agreements with certain investors led by members of management and the Board of Directors as well as a new institutional investor for the purchase of units, with each consisting of one share of its common stock and one warrant to acquire one share of its common stock.
Read more ...
World’s first active bone conduction implant coming to the U.S. market in 2018. DURHAM N.C MED-EL USA announced that the U.S. Food and Drug Administration (FDA) has granted de novo clearance for the BONEBRIDGE™ bone conduction hearing implant system for individuals 12 years and older who have been diagnosed with the conductive hearing loss, mixed hearing loss, or single-sided deafness. Since its introduction in Europe in 2012, BONEBRIDGE remains the world’s first and only active bone conduction hearing implant and is widely considered a breakthrough in bone conduction technology.
Read more ...

Kypha, a medical diagnostics company developing specialized biomarker testing solutions for precision monitoring of immune status and inflammation, has acquired Biosensia, a diagnostics platform and contract development company that strengthens Kypha’s product commercialization. This acquisition demonstrates Kypha’s commitment to meet the need for universally accessible, reliable and timely immune status results in virtually any setting from acute hospital care, to centralized laboratories, physician offices and home use.

Read more ...
The National Institutes of Health announced that it has set aside up to $45.5 million over the next four fiscal years to fund a series of grants as part of its Somatic Cell Genome Editing program. The program is a $190 million initiative launched earlier this year to help improve delivery mechanisms for targeted gene editing tools in patients, to develop new genome editors, and to develop assays for testing the editing tools' efficacy and safety in human and animal cells.
Read more ...
23andMe has received a $300 million equity investment disclosed by GlaxoSmithKline (GSK), under a collaboration designed to use genetic data to identify new drug targets, and thus accelerate development of new therapies for both companies. The collaboration is intended to combine 23andMe’s expertise in gathering and analyzing data from the 5 million customers in its research platform—which the company says includes the world's largest consented, re-contactable database—with GSK’s know-how in R&D and commercialization.
Read more ...

Upcoming Events

> Lab-on-a-Chip and Microfluidics World Congress 2018
(October 1 - October 3, Coronado Island, California)

> Precision CRISPR Congress
(October 22 - October 24, London, UK)

> Medical MEMS and Sensors 2018
(November 7 - November 8, Santa Clara, USA)


Point of Need Testing & Liquid Biopsy Technology and Market Overview:Challenges, market trends and new solutions
Discover the presentation held by Asma Siari at LOAC Europe 2018, on June 5, 2018, in Rotter...
Convergence of Biosensors and mHealth: application trends and market opportunities
Discover the presentation held by Jérôme Mouly at IEK Forum 2018, on May 22nd 2018, in Tai...
When wearables meet connected healthcare: ready for a disruption?
Discover the presentation held by Benjamin Roussel at Medical Wearables 2018, on May 17th 20...

Access to all our presentations